2024 Abstract Guidelines & Poster Submission

The submission deadline was December 15, 2023 11:59 PM ET.

The Late-Breaking Abstract Portal is now closed as of February 5, 2024.
2024 Late-Breaking Abstract Guidelines

Late-breaking abstracts for particularly high-profile projects will be considered for oral presentations via MDA’s late breaking abstract portal starting on January 5, 2024 – February 5, 2024. Submissions past this final deadline will not be accepted with no exceptions. All late-breaking notifications will be sent no later than February 12, 2024.

Late-breaking abstracts must not have been presented, accepted for presentation, or published at any other scientific meeting or journal at the time of submission and must contain data that was only made available after the December 15, 2023 abstract submission deadline. Some oral presentation slots will be dedicated to late-breaking abstracts of high-impact.

Abstract Deadlines & Approvals:

For those submitting an abstract who would like to be considered for oral presentations at the 2024 MDA Clinical & Scientific Conference, highest priority will be given to those who submit abstracts on or before October 31, 2023. Final deadline for oral presentation consideration is December 15, 2023. All abstracts automatically qualify for the poster session. Should there be any questions regarding this policy, please contact [email protected].

NEW for 2024! MDA Conference “Poster Showcase”

Every poster submitted will qualify for the 2024 MDA Conference Poster Showcase. Among them, six (6) abstracts will be chosen for a 5-minute oral presentation during the Networking & Poster Reception, which will take place in the exhibit hall on Monday and Tuesday evenings. This unique “roaming poster showcase” will move around the reception area, allowing amplified talks to be delivered alongside the selected posters.


For those submitting an abstract only as a poster submission at the 2024 MDA Clinical & Scientific Conference abstracts must be submitted on or before December 15, 2023.

Poster Session Options

Sunday, March 3, 2024
6:00 PM – 8:00 PM ET

Monday, March 4, 2024
6:00 PM – 8:00 PM ET

Tuesday, March 5, 2024
6:00 PM – 8:00 PM ET

*All times are subject to change.

 Abstract Approvals

All abstracts falling within the specified categories will be granted approval for presentation in our combined in-person and virtual poster hall, from Sunday, March 3, 2024, to Tuesday, March 5, 2024. For those intending to present their posters in person, we highly advise registering for the conference before December 31, 2023, to benefit from the early bird registration pricing.

Oral Presentation Approvals

The review process for abstracts submitted for oral presentations will start during the week of October 31, 2023. Submitters will begin receiving acceptance notifications for their abstracts for ORAL presentations from approximately November 15, 2023, to December 15, 2023. Once you receive a notification confirming the selection of your abstract for an oral presentation, we strongly advise registering for the in-person conference before the early bird registration deadline of December 31, 2023.

Abstracts selected for oral presentation submitted between November 1 and December 15, 2023 will be notified no later than January 8, 2024.

Abstract Submission Guidelines

The first author (presenting author) will receive all future correspondence from MDA regarding the abstract. Abstract titles should be 150 characters including spaces. Abstract body should not exceed 300 words.

Authors may submit abstracts on the following categories in neuromuscular disease (NMD) research and care:

2024 Abstract Print Guidelines

In-Person Poster Guidelines:

Virtual Poster Guidelines:

2024 MDA Embargo Policy

All abstracts accepted for the 2024 MDA Clinical & Scientific Conference will be available in the Abstract Library starting Wednesday, February 14, 2024*.

While authors may publish that their poster has been selected for inclusion in the conference program, data from the final poster presentation may not be shared in any form (print, broadcast or online publication, media release or conference presentation) prior to its official presentation at MDA Conference 2024 which will be Sunday, March 3, 2024, 6:00PM ET. Author(s) retains copyright of his or her abstract and poster.

Encores are permitted provided that: (i) copyright requirements from the initial conference are respected and (ii) prior presentations are disclosed.

Once an abstract author has confirmed their role as a presenter, it is highly recommended for both the author and their organization to promote the presentation by sharing the title, author’s name, and scheduled time through various channels, tagging MDA when appropriate. Furthermore, following the author’s acceptance, the title, name, and presentation time will be included in the upcoming update of the interactive program on the MDA website.

All presentations at the Annual Conference will be streamed live, recorded, and exclusively accessible on demand to registered participants for a duration of one year following the conference’s conclusion.

Questions about the abstract submission process or poster session guidelines, please contact [email protected].

*Dates subject to change